By Counterforce Health Team in Gattex (teduglutide) —

Renewing Gattex (Teduglutide) Approval with Cigna in New Jersey: Complete Guide to Documentation and Deadlines

Quick Answer: Cigna requires specific renewal documentation for Gattex (teduglutide) including proof of reduced parenteral nutrition needs, lab results from the past 6 months (bilirubin, alkaline phosphatase, lipase, amylase), and colonoscopy documentation if you've been on therapy for over a year. Contact Accredo specialty pharmacy 2 weeks before your supply runs out to initiate renewal. If denied, New Jersey's Independent Health Care Appeals Program (IHCAP) provides external review within 45 days at no cost to you.

Table of Contents

  1. When to Start Your Renewal Process
  2. Required Documentation for Renewal
  3. Building Your Renewal Packet
  4. Submission Timeline and Decision Windows
  5. If Your Coverage Lapses
  6. Annual Plan Changes to Monitor
  7. Personal Progress Tracker
  8. Appeals Process in New Jersey
  9. FAQ

When to Start Your Renewal Process

Start your Gattex renewal process 2 weeks before your current supply runs out. This timing allows Accredo specialty pharmacy to coordinate with your prescriber and handle any insurance reauthorization requirements.

Key Renewal Triggers

  • Prescription expiration: Most Gattex prescriptions are written for 12 months
  • Insurance plan changes: New plan year (January 1st) or mid-year plan switches
  • Formulary updates: When Cigna moves Gattex to a different tier or adds restrictions
  • Clinical status changes: Significant improvement or deterioration in your condition
Tip: Set a calendar reminder 3 weeks before your prescription expires. This gives you a buffer if your doctor needs time to complete renewal paperwork.

Contact Accredo at 877-826-7657 (Mon–Fri 7am–10pm, Sat 7am–4pm CST) to check your renewal status and coordinate with your gastroenterologist.

Required Documentation for Renewal

Cigna's 2024 renewal requirements for Gattex are specific and must demonstrate ongoing medical necessity:

Clinical Response Documentation

Your gastroenterologist must provide evidence that Gattex therapy has improved your condition, specifically:

  • Parenteral nutrition reduction: Documentation showing you've reduced PN dependency or volume by at least 20% from baseline
  • Treatment response: Clinical notes describing improvements in intestinal absorption, weight stability, or reduced dehydration episodes

Mandatory Laboratory Monitoring

Lab results from within the past 6 months are required:

  • Bilirubin
  • Alkaline phosphatase
  • Lipase
  • Amylase

These labs screen for hepatic and pancreatic complications that can develop with long-term teduglutide use.

Surveillance Requirements

If you've been on Gattex for more than one year:

  • Colonoscopy documentation: Required after 1 year of treatment, then at least every 5 years
  • GI surveillance: Any additional imaging or procedures your doctor has ordered

Safety Confirmations

Your prescriber must confirm:

  • No active intestinal obstruction
  • No active malignancy
  • Prescribed dose remains within FDA-approved labeling for your weight and diagnosis

Building Your Renewal Packet

Core Documents Checklist

  • Completed prior authorization renewal form (obtain from Cigna or Accredo)
  • Prescriber's clinical summary letter
  • Lab results (bilirubin, alkaline phosphatase, lipase, amylase) from past 6 months
  • Parenteral nutrition logs showing baseline vs. current requirements
  • Colonoscopy report (if applicable based on treatment duration)
  • Current prescription with refill information

Medical Necessity Letter Structure

Your gastroenterologist's letter should address:

  1. Diagnosis confirmation: Short bowel syndrome with parenteral nutrition dependence
  2. Treatment response: Specific reduction in PN volume, frequency, or caloric needs
  3. Current clinical status: Weight, hydration, nutritional parameters
  4. Ongoing need: Why continued Gattex therapy is medically necessary
  5. Safety monitoring: Lab results and surveillance completed per guidelines
  6. Dosing rationale: Current dose and frequency based on FDA labeling
Clinician Corner: Include specific numbers when possible. Instead of "patient improved," write "patient reduced PN from 7 days/week to 4 days/week" or "decreased PN volume from 2000mL to 1200mL daily."

Submission Timeline and Decision Windows

Optimal Submission Schedule

  • 3 weeks before supply runs out: Contact Accredo to initiate renewal
  • 2 weeks before: Ensure all documentation is submitted
  • 1 week before: Follow up on approval status

Cigna Decision Timeline

  • Standard review: 15 business days from complete submission
  • Expedited review: 72 hours if urgent (risk of hospitalization or significant deterioration)

If Additional Information is Requested

Cigna may request peer-to-peer review or additional clinical documentation. Respond within:

  • 14 days for standard requests
  • 72 hours for expedited requests

If Your Coverage Lapses

Emergency Supply Options

Pharmacy Emergency Supply: New Jersey allows pharmacists to dispense up to a 30-day emergency supply while prior authorization is pending. Contact Accredo immediately to request this option.

Clinical Monitoring During Gaps: Short interruptions (less than 7 days) typically don't require immediate parenteral nutrition changes, but monitor for:

  • Increased stool output
  • Dehydration symptoms
  • Weight loss
  • Need to increase PN support

Bridge Therapy Considerations

If your coverage lapse extends beyond a week:

  • Document any clinical deterioration: Increased PN requirements strengthen your medical necessity case for reauthorization
  • Maintain detailed logs: Track parenteral nutrition volume, frequency, and any symptoms
  • Contact your gastroenterologist: They may need to temporarily adjust your PN regimen

Patient Assistance Options

Takeda Patient Assistance Program: Provides free Gattex for eligible patients with household income up to 500% of Federal Poverty Level. Application takes 2-3 weeks.

Co-pay Assistance: Up to $25,000 annually for commercial insurance patients, reducing costs to as little as $10/month. Cannot be used with Medicare or Medicaid.

From our advocates: We've seen patients successfully bridge coverage gaps by combining pharmacy emergency supplies with expedited appeals. One patient maintained therapy continuity by requesting a 30-day emergency supply while their gastroenterologist submitted an expedited peer-to-peer review, which was approved within 48 hours.

Annual Plan Changes to Monitor

Formulary Updates

Cigna's formulary can change January 1st each year. Monitor for:

  • Tier changes: Gattex moving to a higher cost-sharing tier
  • New restrictions: Additional prior authorization requirements or quantity limits
  • Coverage removal: Rare, but possible for specialty medications

Plan Design Changes

  • Specialty pharmacy network: Verify Accredo remains your designated specialty pharmacy
  • Prior authorization policies: New clinical criteria or documentation requirements
  • Appeals processes: Updated forms, deadlines, or submission methods

Action Steps for Plan Changes

  1. Review your Annual Notice of Changes (ANOC) in September/October
  2. Compare alternative plans during open enrollment (October 15 - December 7)
  3. Contact Counterforce Health if you need help navigating complex coverage changes or preparing appeals documentation

Personal Progress Tracker

Treatment Response Log

Track these metrics to support your renewal:

Month PN Days/Week PN Volume (mL) Weight (lbs) Notable Symptoms Lab Date

Important Dates

  • Current prescription expires: _________
  • Last colonoscopy: _________
  • Next lab draw due: _________
  • Renewal submission target: _________

Contact Information

  • Gastroenterologist: _________
  • Accredo specialty pharmacy: 877-826-7657
  • Cigna member services: _________
  • Your member/group ID: _________

Appeals Process in New Jersey

If Cigna denies your Gattex renewal, New Jersey provides robust appeal rights through the Independent Health Care Appeals Program (IHCAP).

Internal Appeals (Required First)

  1. First-level internal appeal: Submit within 180 days of denial
  2. Second-level internal appeal: If first level is denied

External Review Through IHCAP

After completing internal appeals, you can request external review:

  • Timeline: Submit within 4 months (180 days) of final internal denial
  • Process: Managed by Maximus Federal Services on behalf of New Jersey
  • Cost: No charge to you; insurer pays all review costs
  • Decision timeline: 45 days for standard review, expedited available for urgent cases

Contact IHCAP: 1-888-393-1062 or New Jersey Department of Banking and Insurance Consumer Hotline: 1-800-446-7467

Required Documents for Appeals

  • Copy of original denial letter
  • All clinical documentation supporting medical necessity
  • Prescriber's detailed letter addressing specific denial reasons
  • Evidence of parenteral nutrition dependence and response to Gattex therapy

Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals by analyzing denial letters, plan policies, and clinical notes to draft point-by-point rebuttals aligned with each payer's specific rules.

FAQ

How long does Cigna prior authorization take for Gattex renewal? Standard review takes up to 15 business days. Expedited review (72 hours) is available if delay would cause serious harm.

What if my labs are slightly abnormal? Cigna may request additional documentation or peer-to-peer review. Your gastroenterologist should provide clinical context and monitoring plan.

Can I switch to a different specialty pharmacy? Gattex must be dispensed through Cigna's designated specialty pharmacy network, typically Accredo. Contact Cigna to confirm current network requirements.

What happens if I miss the renewal deadline? Request a pharmacy emergency supply immediately and submit an expedited prior authorization. Document any clinical deterioration during the gap.

Does step therapy apply to Gattex renewals? No, step therapy typically applies only to initial authorizations. Renewals focus on ongoing medical necessity and safety monitoring.

How often do I need colonoscopy surveillance? After 1 year of Gattex therapy, then at least every 5 years per FDA labeling and most payer policies.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance coverage policies change frequently. Always verify current requirements with your insurer and consult your healthcare provider for medical decisions. For personalized assistance with complex coverage issues, consider consulting with healthcare coverage specialists like Counterforce Health, who help patients navigate insurance denials and appeals processes.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.